Perspective Therapeutics (CATX) Earnings Date & Reports

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CATX is expected to report earnings to fall 45.23% to -31 cents per share on May 14

Perspective Therapeutics CATX Stock Earnings Reports

Q1'25

Est.

$-0.31

Q4'24

Missed

by $0.30

Q3'24

Est.

$-0.21

Q2'24

Missed

by $0.16

Q1'24

Est.

$-0.02

The last earnings report on March 26 showed earnings per share of -56 cents, missing the estimate of -26 cents. With 1.24M shares outstanding, the current market capitalization sits at 751.25M.

View a ticker or compare two or three

Compare

CATX